-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, Osecon (002755.SZ) issued an announcement. Jiangsu Aosaikang Biomedical Co., Ltd., a subsidiary of the company, recently received the “Notice of Acceptance” issued by the State Drug Administration, and the application for registration and marketing license for domestically produced drugs of the company's innovative drug olmetotazumab was accepted.

Zhitongcaijing·11/04/2026 11:09:17
Listen to the news
Zhitong Finance App News, Osecon (002755.SZ) issued an announcement. Jiangsu Aosaikang Biomedical Co., Ltd., a subsidiary of the company, recently received the “Notice of Acceptance” issued by the State Drug Administration, and the application for registration and marketing license for domestically produced drugs of the company's innovative drug olmetotazumab was accepted.